Contact Us
Drug Search Results
More Filters [+]

Phytomenadione

Alternative Names: phytomenadione, phylloquinone, konakion, phytonadione, vitamin k1, mephyton, aquamephyton, vitaped, m.v.i. pediatric
Latest Update: 2024-08-29
Latest Update Note: Clinical Trial Update

Product Description

Phytonadione (vitamin K1) is a medication used to treat and manage vitamin K deficiency, which is a significant risk factor for intracranial hemorrhage and other bleeds. (Sourced from: https://www.ncbi.nlm.nih.gov/books/NBK557622/)

Mechanisms of Action: Vitamin K Agonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Injection

FDA Designation: None *

Approval Status: Approved

Approved Countries: Algeria | Argentina | Australia | Austria | Bangladesh | Belgium | Brazil | Bulgaria | Canada | Chile | China | Colombia | Croatia | Cyprus | Czech | Denmark | Dominican Republic | Ecuador | Egypt | Finland | France | Germany | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Italy | Jordan | Korea | Lebanon | Lithuania | Luxembourg | Malaysia | Malta | Mexico | Morocco | Netherlands | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Russia | Saudi Arabia | Serbia | Slovakia | Slovenia | South Africa | Spain | Sri Lanka | Sweden | Switzerland | Taiwan | Thailand | Tunisia | Turkey | Ukraine | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Biliary Fistula | Intestinal Fistula | Colitis | Enteritis | Cystic Fibrosis | Vitamin K Deficiency | Vitamin K Deficiency Bleeding | Celiac Disease | Colitis, Ulcerative | Injuries/wounds Unspecified | Vitamin D Deficiency

Known Adverse Events: Tachycardia | Hypotension | Dizziness | Dysgeusia | Dyspnea | Cyanosis | Flushing | Angioedema | Diplopia | Headache | Erythema | Urticaria | Pruritus | Anaphylaxis | Edema

Company: Elanco Animal Health
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Phytomenadione

Countries in Clinic: China, United States

Active Clinical Trial Count: 2

Highest Development Phases

Phase 2: Glioblastoma

Phase 1: Vitamin K Deficiency Bleeding

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
BPM31510IV-11

P2

Recruiting

Glioblastoma

2025-02-24

CTR20232289

P1

Active, not recruiting

Vitamin K Deficiency Bleeding

None

Recent News Events

Date

Type

Title

08/21/2024

News Article

 Herbalife Scientists to Showcase Advancements in Ingredient Safety and Nutritional Quality at 2024 AOAC INTERNATIONAL Annual Meeting

06/24/2024

News Article

 Vitamin K2 Market worth $265 million by 2029 - Exclusive Report by MarketsandMarkets™

10/04/2023

News Article

 Anticoagulant Reversal Drugs Market Set To High Growth, New Innovative Technologies, Business Opportunities and Forecast to 2023

09/29/2023

News Article

 Vitamin K Market Overview, Size, Share and Forecast 2031

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions